Sanofi SA vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Sanofi SA trades at $43.7 (market cap $104.30B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $39.45. The key difference: Sanofi SA pays a 5.55% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.
| SNY | XDTE | |
|---|---|---|
Market Cap | $104.30B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $52.34 | $44.76 |
52-Week Low | $41.33 | $36.00 |
Enterprise Value | $124.19B | — |
Dividend Yield | 5.55% | — |
Trailing returns across standard periods
Latest headlines on both assets
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →